Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05382754 · ClinicalTrials.gov registry record · NA
Home Apnea Testing in CHildren Trial
A NA study of Sleep Disturbance and Sleep Apnea, Obstructive, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 317
- Enrollment target
- 1
- Study location
NCT05382754: Recruiting NA study of Sleep Disturbance and Sleep Apnea, Obstructive, sponsored by Children's Hospital of Philadelphia.
NCT05382754 is a NA study of Sleep Disturbance and Sleep Apnea, Obstructive that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 317 participants, above the 172-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (84% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05382754, a NA study of Sleep Disturbance and Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 317 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.
Primary Outcome
Obstructive sleep apnea (OSA) defined as an obstructive apnea hypopnea index of greater than 2 events/hour on both home sleep apnea test (HSAT) and polysomnography (PSG).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Home sleep apnea test
- DIAGNOSTIC_TEST In-lab polysomnography
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT05382754 shows while recruiting
NCT05382754 is an interventional study that assigns participants to a tested intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap, above the 172-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (84% higher).
The record links to 4 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 2 interventions - of which Home sleep apnea test is the first listed.
NCT05382754 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05382754 about?
NCT05382754 is a clinical study titled "Home Apnea Testing in CHildren Trial". This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.
What is the current status of trial NCT05382754?
This trial is currently recruiting. It is a NA study. The enrollment target is 317 participants. The study started on 2023-03-29. Estimated completion is 2027-07.
What conditions does trial NCT05382754 study?
This clinical trial studies the following conditions: Sleep Disturbance, Sleep Apnea, Obstructive, Sleep Disorder, Sleep Apnea Syndromes.
What interventions are being tested in trial NCT05382754?
The interventions under investigation include: Home sleep apnea test (DIAGNOSTIC_TEST), In-lab polysomnography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05382754?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05382754 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05382754's enrollment target sits among peer trials
317 9th of 56 higher than 48 of 56 other Sleep Disturbance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disturbance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adjunctive Bright Light Therapy for Opioid Use Disorder
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
RECRUITING · NA
-
Sleep Promotion Program Primary Care
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
SPARK Healthy Sleep
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI